Researchers Identify Novel Class of Drugs for Prostate Cancers That Disrupts Growth Signaling
UT Southwestern Medical CenterA new study on prostate cancer describes a novel class of drugs developed by UT Southwestern Medical Center researchers that interrupts critical signaling needed for prostate cancer cells to grow.